A carregar...

New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochloride

Oral administration of sapropterin hydrochloride, recently approved for use by the US Food and Drug Administration and the European Commission, is a novel approach for the treatment of phenylketonuria (PKU), one of the most common inborn errors of metabolism. PKU is caused by an inherited deficiency...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Harding, Cary O
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921259/
https://ncbi.nlm.nih.gov/pubmed/20714359
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!